When the subject of Lyme illness comes up, Robert F. Kennedy Jr. typically tells a story about standing in a bathtub in Westchester County, New York, within the Nineteen Eighties, selecting virtually 30 ticks off of himself after a day within the woods.
He’s had the attribute bullseye rash of Lyme illness and says all of his youngsters have had the tickborne sickness, two of them severely affected.
As secretary of the US Department of Health and Human Services, Kennedy has promised to tackle Lyme illness, which is an excellent larger downside now than it was 40 years in the past. At a roundtable discussion he convened in December with sufferers, clinicians and researchers, he pledged larger help for bettering diagnostics and remedy.
“We’ve got to figure out a way to make it safe for children to go back in the woods again,” Kennedy mentioned.
Last week, a potential technique of doing so emerged: Pfizer said it deliberate to file for regulatory approval of a Lyme illness vaccine that could be the primary available on the market in additional than 20 years.
But its path within the US could possibly be rocky, not least due to Kennedy himself, who’s embraced each anti-vaccine views and conspiracy theories, together with that Lyme illness could also be a bioweapon engineered by US authorities scientists throughout the Cold War.
Beyond Kennedy, although, the US has a difficult historical past with Lyme illness vaccines, and a few of these points haven’t gone away.
The downside of Lyme illness is big – and getting worse.
About 476,000 individuals are estimated to be recognized with and handled for Lyme illness every year within the US, and the areas the place it’s found have been increasing in virtually each course, helped by local weather change and, probably, altering land use.
“Lyme is entering areas where it didn’t occur before,” mentioned Dr. Richard Ostfeld, a illness ecologist on the Cary Institute of Ecosystem Studies in Millbrook, New York.
The illness is attributable to micro organism referred to as Borrelia burgdorferi, and it’s unfold to people by blacklegged ticks. It may cause fever, fatigue and an oval or bullseye-like pores and skin rash; with out remedy, the an infection can unfold to the joints, coronary heart and nervous system, inflicting arthritis, persistent ache and different issues.
Most circumstances caught early are handled successfully with antibiotics, however some sufferers have longer-lasting and typically devastating signs even after remedy, a situation referred to as post-treatment Lyme disease syndrome, or power or lengthy Lyme.
And an growing variety of individuals are weak because the ticks that carry Lyme-causing micro organism are on the transfer. Climate change is enabling them to unfold into previously colder climes, Ostfeld mentioned, extending the nice and cozy intervals of the yr that permit them to search hosts, which the ticks can’t do when the temperature is within the 30s or beneath.
But they’re additionally shifting into hotter areas, together with southward within the US, an enlargement that could also be pushed by how we dwell.
“Suburbanization and the fragmentation of forests exacerbates Lyme disease risk,” Ostfeld mentioned. And that has to do with mice and different rodents that carry Lyme-causing micro organism and are notably alternative hosts for blacklegged ticks, which then give the micro organism to us.
Those mice – white-footed mice particularly – “thrive in areas that are disturbed by people,” Ostfeld mentioned.
Lyme’s toll was dangerous sufficient a number of a long time in the past that a number of pharmaceutical corporations spent years and untold sums of cash growing vaccines to attempt to forestall it. One, drugmaker GSK’s Lymerix, was profitable in getting to market, authorized by the US Food and Drug Administration in 1998.
But the percentages have been stacked in opposition to it from the start, with lukewarm endorsements from authorities our bodies because it made its method by the regulatory course of.
“The benefits are on the side of the vaccine in the short term,” Dr. Dixie Snider of the US Centers for Disease Control and Prevention is quoted as saying after an FDA advisory panel beneficial its approval in May of 1998. “In the long term, we don’t know.”
The New York Times headlined its story on the approval in December of that yr: “Lyme vaccine is approved, with caveat,” mentioning that the FDA “was unusually cautious in recommending use of the vaccine.”
The caveats included that the vaccine was examined solely in folks ages 15 to 70, so it wasn’t cleared for different age teams, and that it took a yr and three doses to attain safety of about 75% in opposition to circumstances of Lyme illness, which means folks would nonetheless want to take precautions.
A tepid advice from the CDC’s vaccine advisers additional sealed its destiny, in accordance to Dr. Paul Offit, then a member of that group, referred to as the Advisory Committee on Immunization Practices.
“The ACIP really killed that product,” he mentioned. “They damned it with faint praise.”
The committee, whose suggestions usually information how vaccines are used within the US, recommended that for individuals who dwell, work or do leisure actions in areas of excessive or average danger for Lyme illness, vaccination “should be considered.”
It wasn’t a routine advice, a stronger endorsement that would have been extra clear, Offit mentioned. And he identified that a routine advice might have served one other goal: doubtlessly offering a type of safety for the vaccine in opposition to litigation by together with it within the Vaccine Injury Compensation Program.
That program was arrange within the Nineteen Eighties after lawsuits in opposition to vaccine producers risked driving them out of the market and creating vaccine shortages; it provides a method to compensate folks discovered to be injured by a vaccine in a no-fault various to the authorized system.
Lymerix hadn’t proven any main security considerations in its main medical trial, which was run in 10,936 folks. But after it bought available on the market, there have been fears the vaccine may trigger a symptom it was aiming to forestall.
“There was a lot of, turns out, erroneous publicity that the vaccine caused arthritis,” mentioned Dr. Eugene Shapiro, a professor of pediatrics and epidemiology on the Yale School of Medicine.
Lawsuits piled up. Researchers reviewed information from a federal database of vaccine opposed occasion studies, finding that of 1.4 million doses of Lymerix that have been distributed in its first 19 months available on the market, there have been 905 occasions reported, together with 59 sufferers with arthritis.
It was a degree effectively beneath what may be anticipated usually within the inhabitants, and an FDA advisory panel concluded in 2001 that there was no affiliation between the vaccine and arthritis.
Nonetheless, curiosity within the vaccine petered out, and in early 2002, GSK pulled it from the market, citing “poor demand.” The firm settled the lawsuits in 2003 for about $1 million.
A second vaccine in opposition to Lyme illness that had proven related, even doubtlessly stronger, ends in medical trials was by no means submitted for approval.
“It’s really a sad story,” vaccine pioneer Dr. Stanley Plotkin informed NCS. “We had a good vaccine that failed because people didn’t use it.”
It’s not clear whether or not the brand new vaccine, from Pfizer and companion Valneva, may have a neater time.
The results they reported final week weren’t a clear win: The vaccine missed one statistical bar in its medical trial however met one other. Pfizer nonetheless mentioned it was “confident in the vaccine’s potential and is planning submissions to regulatory authorities.”
The new vaccine takes a related method to Lymerix, delivering a floor protein discovered on Lyme micro organism so the physique’s immune system generates antibodies in opposition to it. It doesn’t cease a tick from biting somebody, but when the antibodies are current when the tick takes a blood meal, they will neutralize the micro organism within the tick’s intestine, stopping an infection.
Pfizer and Valneva’s outcomes confirmed that 4 doses of the vaccine delivered over two seasons decreased circumstances of Lyme illness by about 75%, related to the efficacy for Lymerix.
The vaccines have a few key variations: Although Lymerix offered safety in opposition to only one kind of floor protein – the type predominant in North America – the newer vaccine protects in opposition to the six most prevalent in North America and Europe.
And although the Lymerix vaccine wasn’t discovered to trigger arthritis, the Pfizer and Valneva vaccine was designed to miss the portion of the floor protein that raised that theoretical danger, Shapiro mentioned. He famous that he acquired a small fee for collaborating in conferences concerning the Pfizer and Valneva vaccine, and he wasn’t concerned with Lymerix.
Whether a Lyme illness vaccine could be embraced broadly now – whilst Lyme incidence has been capturing up – is “the big question,” mentioned Dr. Linden Hu, co-director of the Tufts University Lyme Disease Initiative and a professor of immunology at Tufts Medical School.
“A four-dose vaccine with 75% efficacy might be a difficult sell,” Hu mentioned, “but for those that are willing, it will be great to have a vaccine as an option for protection again.”
Some advocacy teams are unenthusiastic. Lorraine Johnson, chief govt officer of LymeDisease.org, famous that “the Lyme community had a sour taste in their mouth” from the expertise with Lymerix, although she acknowledged it wasn’t proved that the vaccine prompted arthritis.
“There were enough patients who became profoundly ill, and physicians were raising the alarm,” she mentioned. “It was taken as a very, very serious threat by the Lyme community.”
Johnson additionally identified that the vaccine protects solely in opposition to Lyme illness, not the variety of different pathogens that will be transmitted by the identical ticks, akin to Powassan virus or the parasite that causes babesiosis.
“Why that matters is, a patient could get a vaccine that covers Lyme and then have a false sense of complacency that they’re covered if they get a tick bite, and they’re not covered because they’ve got the potential for these other tickborne infections,” she mentioned.
The group, Johnson mentioned, has been behind broader approaches. “You really want to have the ticks falling off of you.”
There are research underway on makes an attempt to accomplish simply that, together with a tablet that goals to kill ticks after they chunk, stopping them from spreading pathogens. Hu famous that his lab was concerned in a part of its testing, in addition to separate work on vaccines for mice within the wild to attempt to lower down transmission. He additionally has labored with Moderna on its mRNA-based Lyme vaccine in improvement.
The tick-killing tablet is within the works at biotech firm Tarsus Pharmaceuticals, which is predicted to begin a midstage medical trial of it over the following few months, with outcomes early subsequent yr.
A key query for the trail of a Lyme illness vaccine within the US is Kennedy himself, who as HHS secretary sits above the FDA and the CDC, pivotal companies for any vaccine’s approval and uptake.
He’s promoted the conspiracy concept that Lyme illness was a bioweapon engineered on the Plum Island Animal Disease Center, a US authorities facility, a narrative that illness ecologist Ostfeld calls “destructive and clearly false.”
Ostfeld pointed to proof suggesting that Lyme-causing micro organism “has existed in essentially its current-day form for hundreds of thousands of years,” and “the tick also has existed in largely its present form for millions of years.”
“The last thing that I would ever use for a bioweapon would be some kind of tickborne disease where the tick doesn’t even transmit the pathogen to its babies,” Ostfeld mentioned. “The tick bites three times in its life and takes two years to do that. What could be less efficient, less operational, as a weapon than something like a tickborne bacterium that can be cleared from your system with antibiotics within a couple weeks?”
Plotkin put it one other method: “Using the technical term, it was bullsh*t.”
Nonetheless, a directive for the Government Accountability Office to put together a report on organic weapons experiments on ticks and tickborne illnesses was included within the 2026 National Defense Authorization Act, signed into legislation by President Donald Trump in December.
It was championed by New Jersey Rep. Chris Smith, founder and co-chair of the Congressional Lyme and Tick-Borne Disease Caucus.
Smith mentioned the purpose of the modification “is to generate insights into the origin, nature, and comorbidities associated with Lyme and other tick-borne pathogens,” which he mentioned he believes will “generate better clinician awareness, diagnostics, treatments and, ultimately, a cure.”
He mentioned he’s supported efforts for greater than three a long time to analysis and develop a vaccine, and he referred to as Pfizer’s outcomes “extremely promising.”
Kennedy has been much less obsessed with Lyme vaccines prior to now. In 2022, when Pfizer and Valneva launched outcomes from earlier-stage trials of their vaccine, Kennedy posted a story on social media from the anti-vaccine advocacy group he led, Children’s Health Defense, that posited “some experts say treatment is a better solution.”
Since taking the helm at HHS, he has overhauled each the childhood vaccine schedule and the CDC’s vaccine advisory committee – strikes now in limbo after an order from a federal decide. His vaccines chief on the FDA is on his method out, and vaccine makers have said they’re pulling again on some improvement due to the surroundings underneath Kennedy.
And regardless of his advocacy for Lyme illness, Kennedy has not centered on vaccination as a answer.
Some of the one mentions of vaccines on the December HHS roundtable on Lyme illness got here from invited lawmakers, together with Sen. Susan Collins of Maine, who mentioned, “One of the most important tools that I hope we’ll continue to research to combat Lyme disease is a vaccine.”
Collins, a Republican, made a related assertion in a query to Kennedy throughout his affirmation listening to final yr, asking him what affect he’d train over new vaccine approvals, “such as one for Lyme disease,” as HHS secretary.
Kennedy pledged, “There is nobody who will fight harder to find a vaccine or a treatment for Lyme disease than me.”
Andrew Nixon, a spokesperson for HHS, informed NCS that “HHS supports rigorous, gold-standard science to better understand, prevent, and treat Lyme disease.”
He didn’t reply to a number of questions on whether or not HHS’s help of prevention efforts extends to vaccines.